(Hypertension. 1996;27:1180-1186.)
© 1996 American Heart Association, Inc.
Articles |
From the Medical Research Institute and Department of Nephrology, Nippon Telegraph and Telephone (NTT) Kanto Teishin Hospital, Tokyo, Japan.
Abstract To assess the role of insulin resistance in obesity hypertension, we examined the change of insulin sensitivity after weight loss in 24 obese hypertensive subjects by the euglycemic hyperinsulinemic glucose clamp method. The results of the 4-week calorie-restricted diet were a weight loss of 10.2% (from 74±12 to 67±11 kg, P<.01) and a decrease in mean blood pressure of 13.1% (from 124±7 to 107±9 mm Hg, P<.01). A decrease in plasma norepinephrine (from 208±74 to 142±52 pg/mL, P<.01) was associated with decreases in plasma renin activity (from 1.06±0.98 to 0.62±0.63 ng/mL per hour, P<.01) and serum aldosterone (from 70±28 to 57±24 pg/mL, P<.05). Glucose infusion rate increased significantly (42.9%), from 809±194 to 1155±251 µmol/m2 per minute. The insulin sensitivity index, which is a measure of the glucose infusion rate divided by plasma insulin, increased significantly (42.6%), from 10.8±3.5 to 15.4±4.4 (µmol/m2 per minute)/(µU/mL). Stepwise multiple linear regression analysis showed that changes of plasma norepinephrine, insulin sensitivity index, plasma renin activity, and age were significant predictive factors for the change of mean blood pressure after weight loss. These results indicate a distinct relation between an improvement of insulin sensitivity and a decrease in blood pressure after weight loss in obese hypertensive subjects. The decrease in blood pressure after weight loss is probably related to the suppression of sympathetic nervous activity.
Key Words: body mass index diet hypertension, obesity insulin resistance norepinephrine renin-angiotensin system
This article has been cited by other articles:
![]() |
M. S. Landa, S. I. Garcia, M. L. Schuman, A. Burgueno, A. L. Alvarez, F. E. Saravia, C. Gemma, and C. J. Pirola Knocking down the diencephalic thyrotropin-releasing hormone precursor gene normalizes obesity-induced hypertension in the rat Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1388 - E1394. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Scopinaro, G. M. Marinari, G. B. Camerini, F. S. Papadia, and G. F. Adami Specific Effects of Biliopancreatic Diversion on the Major Components of Metabolic Syndrome: A long-term follow-up study Diabetes Care, October 1, 2005; 28(10): 2406 - 2411. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Garcia, M. S. Landa, P. I. Porto, A. L. Alvarez, M. Schuman, S. Finkielman, and C. J. Pirola Thyrotropin-Releasing Hormone Decreases Leptin and Mediates the Leptin-Induced Pressor Effect Hypertension, February 1, 2002; 39(2): 491 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Sjostrom, M. Peltonen, H. Wedel, and L. Sjostrom Differentiated Long-Term Effects of Intentional Weight Loss on Diabetes and Hypertension Hypertension, July 1, 2000; 36(1): 20 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kobayashi, S. Maejima, T. Ikeda, and M. Nagase Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis Nephrol. Dial. Transplant., January 1, 2000; 15(1): 65 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Williams, J. B. Chambers, O. L. May, R. P. Henderson, M. E. Rashotte, and J. M. Overton Concurrent reductions in blood pressure and metabolic rate during fasting in the unrestrained SHR Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2000; 278(1): R255 - R262. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Williams, J. B. Chambers, R. P. Henderson, M. E. Rashotte, and J. M. Overton Cardiovascular responses to caloric restriction and thermoneutrality in C57BL/6J mice Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1459 - R1467. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |